These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 22474880)

  • 1. Atypical insufficiency type femoral stress fractures in patient on bisphosphonates.
    Evangelista PT; Levine SM
    Med Health R I; 2012 Feb; 95(2):61-2. PubMed ID: 22474880
    [No Abstract]   [Full Text] [Related]  

  • 2. The cumulative effect of bisphosphonates and statins on stress fractures. Is it a failure of steroid biosynthesis? Case Report.
    Dzugan SS; Dzugan SA
    Neuro Endocrinol Lett; 2016; 37(2):97-101. PubMed ID: 27179570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Is SSBT associated with atypical femoral fracture? SSBT isn't associated with atypical femoral fracture].
    Soen S
    Clin Calcium; 2012 Jun; 22(6):919-22. PubMed ID: 22653034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical outcome of atypical subtrochanteric and femoral fracture related to bisphosphonates use in osteoporotic patients with or without teriparatide treatment.
    Yeh WL; Su CY; Chang CW; Chen CH; Fu TS; Chen LH; Lin TY
    BMC Musculoskelet Disord; 2017 Dec; 18(1):527. PubMed ID: 29237448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Is SSBT associated with atypical femoral fracture? SSBT is associated with atypical femoral fracture - pathophysiology of atypical femoral fractures - ].
    Mashiba T
    Clin Calcium; 2012 Jun; 22(6):914-8. PubMed ID: 22653033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical femur fractures.
    Borrelli J; Lane J; Bukata S; Egol KA; Takemoto R; Slobogean G; Morshed S
    J Orthop Trauma; 2014; 28 Suppl 1():S36-42. PubMed ID: 24476604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical femoral fractures and their relation to bisphosphonate use.
    Tripto-Shkolnik L
    Isr Med Assoc J; 2013 Aug; 15(8):447-50. PubMed ID: 24079069
    [No Abstract]   [Full Text] [Related]  

  • 8. [Osteoporosis--new therapeutic possibilities. The Danish Bone Society].
    Langdahl BL; Rejnmark L;
    Ugeskr Laeger; 2008 Mar; 170(12):1043. PubMed ID: 18397661
    [No Abstract]   [Full Text] [Related]  

  • 9. What is the optimal duration of bisphosphonate therapy?
    Ott SM
    Cleve Clin J Med; 2011 Sep; 78(9):619-30. PubMed ID: 21885695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there a case for the early use of bisphosphonates in smouldering myeloma and MGUS? (Bisphosphonates in SMM & MGUS).
    Sanders J; Crawford B; Gibson J; Joy Ho P; Iland H; Joshua D
    Int J Lab Hematol; 2007 Oct; 29(5):395-7. PubMed ID: 17824924
    [No Abstract]   [Full Text] [Related]  

  • 11. Atypical Fractures of the Femur Associated with Chronic Treatment with Bisphosphonates.
    Fijewski G; Szostakowski B; Górski R; Modzelewski P; Dudek P; Małdyk P
    Ortop Traumatol Rehabil; 2016 May; 18(3):239-249. PubMed ID: 28157080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Images in emergency medicine. Elderly woman with right thigh pain. Atypical femur fracture.
    Pulia MS; Hansen B
    Ann Emerg Med; 2014 Mar; 63(3):370, 374. PubMed ID: 24528947
    [No Abstract]   [Full Text] [Related]  

  • 13. Atypical diaphyseal femur fractures in patients with prolonged administration of bisphosphonate medication for osteoporosis.
    Horning JA; Czajka J; Uhl RL
    Orthopedics; 2010 Dec; 33(12):902. PubMed ID: 21117565
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pharmaceutical care of an osteoporosis patient with hypothyroidism].
    Heumüller R; Kretschmer I; Döhler N; Wittich R; Menzen M; Homann J; Jaehde U
    Med Monatsschr Pharm; 2009 Dec; 32(12):459-63. PubMed ID: 20088348
    [No Abstract]   [Full Text] [Related]  

  • 15. Prophylactic intramedullary fixation for bisphosphonate-related subtrochanteric stress fracture.
    Fowler JR; Criner K; Craig MR
    Orthopedics; 2012 Jun; 35(6):e954-7. PubMed ID: 22691674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisphosphonates and low-impact femoral fractures: current evidence on alendronate-fracture risk.
    Schneider JP
    Geriatrics; 2009 Jan; 64(1):18-23. PubMed ID: 19256578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical femur fractures.
    Tyler W; Bukata S; O'Keefe R
    Clin Geriatr Med; 2014 May; 30(2):349-59. PubMed ID: 24721373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Atypical femoral fractures in long-term osteoporotic treatment with bisphosphonates].
    Thein R; Tenenbaum S; Chechick O; Hershkovitz O; Chechik A; Caspi I
    Harefuah; 2012 Sep; 151(9):532-6, 555. PubMed ID: 23367748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bilateral femur fractures associated with short-term bisphosphonate use.
    Rifai A; Pourtaheri S; Carbone A; Callaghan JJ; Stadler CM; Record N; Issa K
    Orthopedics; 2015 Feb; 38(2):e139-42. PubMed ID: 25665120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical fractures: An issue of concern or a myth?
    Al-Ashqar M; Panteli M; Chakrabarty G; Giannoudis PV
    Injury; 2018 Mar; 49(3):649-655. PubMed ID: 29338853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.